| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.03 |